CD4 and colon carcinoma: To evaluate which immune cell populationswere mediating antitumor efficacy, we administered depletion antibodiesspecific for CD4, CD8α, or colony stimulating factor-1 receptor(CSF1R) to MC38 colon carcinoma-bearing mice prior to starting polymertherapy.